Medical Science Liaison-Inhaled-Wuhan

JOB PURPOSE 工 作 目 的

Summarizes the job’s purpose or role and why it exists in the organization

概 述 工 作 的 目 的 或 角 色 及 其 在 机 构 内 的 价 值

Field-based position responsible for implementation of activities for establishment of scientific leadership of AstraZeneca. This includes development and enhancement of professional relationships with healthcare professionals, building deep scientific understanding of AstraZeneca compounds. Driving positive opinions for the scientific and clinical value of AZ compounds for patients’ needs. Deliver medical education and clinical support to medical professionals, training sales teams and involvement in development of brand strategy. The position may also be involved in review of product materials and response to medical queries.

There are 4 levels in MSL technical role, i.e. MSL, Sr. MSL, Executive MSL and Principle MSL.

NATURE & SCOPE 工 作 性 质 及 范 围

(a) Organization structure / 组 织 机 构

( Please attached an updated organization chart of your team 请 附 上 你 所 属 团 队 的 最 新 结 构 图)

Depending on specific team structure

Functionally reports to / 功 能 汇 报 (Please specify position title 请 注 明 职 位 名 称)

Depending on specific team structure

Operationally reports to / 运 作 汇 报

Depending on specific team structure

Position title of subordinates/ Number of subordinate / 下 属 的 岗 位 名 称 及 人 数

Depending on specific team structure

(b) Key working relationships / 主 要 工 作 关 系

Internal contacts within AZ / 内 部 联 系

Other Medical affairs function(Evidence Generation) Commercial (i.e., Sales, Marketing, Market Access…) and Compliance

External contacts with organizations outside AZ / 外 界 联 系

• •KEE/HCP
• •Health Care Professionals
• •Study Investigators
• •Payer Customers and Policy Makers

（c）Working Location / 工作地点 （Optional）

DUTIES & RESPONSIBILITES / 主 要 职 责

Key Result Areas

(in order of importance)

Key Tasks

Measurements

External Medical & Scientific engagement

Build, enhance and maintain the engagement with scientific leader

• •60% of time in field engaging HCPs and external stakeholders across territory and brands
• •Proactively identify HCPs with high levels of scientific expertise in local treatment practice to collaborate on specific medical marketing activities
• •Development and implementation of KEE engagement plan in collaboration with line manager. Review with line manager this plan every quarter, develop KEE visit plan- this includes pre call visit/engagement plan with clear objective of the visit, key points discussion for the visit, data to be shared and discussed with the KEE
• •Develop own scientific knowledge for discussion on all aspects of the data to be shared with KEE in a scientific, objective and balanced way through 1:1 discussions. Prepare for such interactions with peer group discussions. Respond to unsolicited requests for information about unapproved AZ products or unapproved uses of approved products, presenting such information in an objective, scientifically balanced, substantiated manner. Develop database of Key external experts and also provide recommendations for advisory board participation

Quantity

• •60% of available time spent meeting KEEs. (Available time = total days minus holidays, weekends, sickness)
• •Complete records of KEE visits and regular review by MSL line manager (define routine review as monthly for new starters and quarterly for non-new starters)
• •Coverage/engagement of KEEs versus plan
• •Improvement in advocacy score

Quality

• •Meeting skills and presentation skills based on in field coaching and assessment annual role play assessment of capabilities and scientific knowledge– use standard assessment form and methodology
• •Feedback from KEEs

Build and maintain trust-based relationships with external stakeholders

• •Build AZ relationship with key external stakeholders (e.g. patient advocacy groups, key medical organizations, hospital pharmacy). Find opportunities to collaborate with such external stakeholders. Provide scientific support in CME events and through appropriate medical sponsorships/ partnership
• •Act as scientific expert in the disease area(s) by presenting therapeutic updates to external stakeholders

• •Quantity of CMEs and Medical Sponsorship versus plan
• •Positive customer feedback post events

Develop or initiate scientific programs to explore unmet medical needs in priority disease area(s)

W o rk with H CPs in s ci e n ti f ic a cti v it i e s th at h e lp a d v a n ce d i s e a s e und e r s t and i n g s u ch a s :

- I d e n tify a n d r e commend KEEs for Advisory Bo a r d s

- I d e n tify p otenti a l s p e a k e r s a n d t rain s p e a k e r s a s app r op ria t e

- I n teract in th e fi e ld with th e me d ical com m un ity in th e c on text of v ario u s me d ical p r o j e ct s , such a s cli n i cal tri a l s , E SR s , s c i e n tif i c ex c h a n ge m ee ti n gs

- Di s c u s s p otenti a l i n v o l v e m e n t in L CM

- R es p o n d t o un s olicited of f l ab e l qu es ti on s f r o m KEEs

A b le t o c ondu ct b as i c d i s c us s i o n s o n cli n ical t rials in t e rms o f st ud y d es ign a n d f e as i b ility

Quantity

• •No. of Advisory Board Meetings versus plan
• •No. of P2Ps/round table discussions versus plan
• •No. of CMEs versus plan
• •No. of ESRs communicated

Quality

• •Positive customer feedback
• •In field observation by line manager and coaching form

Medical & Scientific Support for internal stakeholders

Act as scientific expert in priority disease area(s) for internal stakeholders

• •Continuously acquire and update necessary scientific knowledge on therapeutic area and relevant compounds
• •Provide the AZ internal stakeholders with an understanding of the local medical community, clinical practice, trends and real or perceived gaps in current scientific knowledge and medical treatment, competitor information
• •Provide regular update on partnerships with HCPs, as speakers, or in the context of medical projects
• •Initiate and conduct appropriate AZ staff training & development on information regarding current and emerging clinical data and emerging trends in clinical medicine and practice within TA
• •To work with internal cross functional team on formulary listing
• •Provide scientific support at AZ sponsored educational events

Quantity

• •% of trainings conducted versus plan
• •No of days providing training versus plan



Quality

• •Feedback on training from participants
• •Feedback from business partners on quality of contribution to Medical and Brand plans – collected by line manager

Personal Development

Continuously demonstrate development of scientific expertise in disease area(s) of company focus

• •Attend relevant scientific congresses and HCP meetings to gather new knowledge on AZ compounds, competitor information and therapeutic area
• •Positive engagement and response to coaching and feedback received from line manager
• •In daily work takes time to reflect on customer interactions and works on areas agreed with line manager as priorities for development. Develop functional capability in the role
• •Proactively demonstrate the AZ Values
• •Identify areas for self-development and discuss developmental needs with line manager using the 70-20-10 principle (experiential learning, coaching/networking/relationship-based learning and classroom training). Active participation in AZ training, projects, and meetings depending on development needs

Quality

• •100% completion of training as required on Medical Academy and AZLearn
• •Feedback on congress report/highlights shared with cross- functional team as planned – completed feedback templates
• •Has a personal development plan and completes identified development activities as planned

Compliance

Compliance with relevant company and industry code of Conduct and also to comply with local country codes

Keep regular update and operate within the relevant Codes of Conduct, Ethical Interactions (EI), including GPEI and SOP